Literature DB >> 447039

The renal and hemodynamic effects of the peritoneovenous shunt for intractable hepatic ascites.

L M Blendis, P D Greig, B Langer, R S Baigrie, J Ruse, B R Taylor.   

Abstract

Fifteen patients with chronic liver disease having a peritoneovenous shunt for chronic intractable ascites were studied prospectively for renal function and hemodynamic changes during balance studies, pre-, peri-, and postoperatively. Shunt insertion caused a rapid redistribution of ascites into the intravascular compartment with hemodilution and significant rises in cardiac output (9 patients) (P less than 0.025) renal blood flow (3 patients) (P less than 0.025), and creatinine clearance (15 patients) (P less than 0.005), and decreases in plasma renin activity (10 patients) and serum aldosterone levels (9 patients) (P less than 0.025). Despite these changes, small repeated doses of furosemide were required to start and maintain a diuresis and natriuresis with sodium excretion rising from 7.2 +/- 4.1 to 174 +/- 44 meq/day (P less than 0.0005) in the 15 patients. At 2 wk postoperatively, the 15 patients had lost a mean of 7.5 kg in weight associated with a persistent improvement in creatinine clearance and a continued natriuresis, 15.9 +/- 7 mEq/day (P less than 0.005), despite no statistically significant change in cardiac output (7 patients) or renal blood flow (4 patients) compared with preoperative levels. This operation is an effective therapy for refractive ascites, but the incidence of potentially fatal complications makes us hesitate to recommend it except for patients resistant to normal conservative measures.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 447039

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  14 in total

1.  Effect of peritoneo-venous shunt on portal pressure.

Authors:  A K Samanta; C M Leevy
Journal:  Gut       Date:  1989-01       Impact factor: 23.059

2.  Treatment of ascites in patients with cirrhosis of the liver.

Authors:  V Arroyo; P Ginés; J Rodés
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

Review 3.  Resistance to loop diuretics. Why it happens and what to do about it.

Authors:  D C Brater
Journal:  Drugs       Date:  1985-11       Impact factor: 9.546

Review 4.  [Peritoneovenous shunt in the treatment of therapy-refractory ascites].

Authors:  C A Eriksen; A Cuschieri
Journal:  Langenbecks Arch Chir       Date:  1988

5.  Morbidity and mortality after peritoneovenous shunt surgery for refractory ascites.

Authors:  D Rubinstein; I McInnes; F Dudley
Journal:  Gut       Date:  1985-10       Impact factor: 23.059

6.  The LeVeen shunt in the elective treatment of intractable ascites in cirrhosis. A prospective study on 140 patients.

Authors:  C Smadja; D Franco
Journal:  Ann Surg       Date:  1985-04       Impact factor: 12.969

7.  Budd-Chiari syndrome associated with oral contraceptive steroids. Review of treatment of 47 cases.

Authors:  J H Lewis; H L Tice; H J Zimmerman
Journal:  Dig Dis Sci       Date:  1983-08       Impact factor: 3.199

8.  Factors that determine refractoriness of ascites to conventional therapy.

Authors:  S Amra; R Elie; I Kronborg
Journal:  CMAJ       Date:  1986-09-01       Impact factor: 8.262

Review 9.  Role of surgical therapy in management of intractable ascites.

Authors:  J Elcheroth; C Vons; D Franco
Journal:  World J Surg       Date:  1994 Mar-Apr       Impact factor: 3.352

Review 10.  Cardiac abnormalities in liver cirrhosis.

Authors:  S S Lee
Journal:  West J Med       Date:  1989-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.